Introducing a new way to treat severe equine asthma.
For horses and ponies held back by equine asthma, treating lower airway inflammation and managing their environment can restore their freedom, but concentrating corticosteroid therapy in the lungs and nowhere else is a challenge. Following 10 years of research, Boehringer Ingelheim are proud to introduce new Aservo® EquiHaler®.
2_01 Home Page Designed for Horses
Designed for horses and the people who care for them
The Aservo® EquiHaler® is designed specifically for use in horses. The product is simple to operate and can be administered with one hand by the owner, leaving the other free to hold the horse. In clinical trials, 95% of horses accepted the treatment with 93% compliance from the owner1,6. To get the best results with your patients we have a range of materials to support you and your clients.
in*hale*a*bil*it*y
/inˈhālˈəˈbilədē/
"Having characteristics that allow respirable particles to follow the inhaled airstream deep into the lung. Easy to inhale."
The new Aservo® EquiHaler® is designed for inhaleABILITY so that treating severe equine asthma is easy, even when breathing is difficult.
Treat with
confidence
Studied in Over
Horses*
Horses treated with Aservo® EquiHaler® demonstrated improved lung function and improved clinical signs in controlled and field studies3,4,5. No significant suppression of serum cortisol means you can reduce the risks commonly associated with systemic corticosteroids.
*Treated with Aservo® EquiHaler® or placebo EquiHaler®
We are here to help
To be contacted by a BI representative enter your email address here